Lecture Notes Review: Biosensors and Protein Structure

Recap from Last Lecture

  • Bacteria-based Biosensors:

    • Utilize engineered bacteria with a stress-inducible promoter linked to a reporter gene.

    • When the stress response is activated (e.g., due to water quality issues), bacteria emit a signal ("flash" a warning).

    • Applications include water quality monitoring.

    • Can be specific (e.g., UO$_{2}^{2+}$) or semi-specific.

    • Comparison of Stress-inducible vs. Constituent Sensors:

      • Constituent: Always "on" when the water supply is OK, or partially "off" if the supply is not OK.

      • Stress-inducible: "off" when water is OK, "on" or partially "off" when water is not OK.

      • The negative control M2G's behavior depends on the context.

    • Commercial products are widely used, and this sensor type is highlighted as an excellent publication.

    • Self-testing function is a key feature.

  • Urban/Industrial Monitoring:

    • Biosensors enable continuous, unattended, real-time monitoring.

    • Concept: Microbial biosensors for detecting endocrine disruptors in urban waterways (e.g., Biosensors & Bioelectronics, 2021).

    • Fabrication: Immobilization of engineered bacteria on an electrode, where cells produce an electric current upon detection.

    • Example: 4-Hydroxytamoxifen (4-HT) as a model endocrine disruptor.

    • Detection can occur in minutes (Nature, 2022).

  • Mammalian Cell-based Biosensors:

    • Involve G-protein coupled receptors, where conformational changes offer unique possibilities.

    • Like bacteria-based sensors, these can be specific (ligand-specific) or semi-specific.

    • Cool Applications: Allergy profilers (activation of HRH2-histamine receptor leads to reporter protein signaling) and neurons for sensing warfare agents.

Enzyme-based Biosensors: Fundamentals

  • Introduction:

    • Enzyme sensors are a key topic for today's lecture and will be included in quizzes and exams.

    • Students are expected to be familiar with basic undergraduate material related to enzymes and proteins.

  • Principles of Enzyme Biosensors:

    • Bioreceptor: An enzyme (e.g., Glucose Oxidase - GOx in a glucose sensor) is attached to a transducer surface.

    • Function: Enzymes are highly selective biocatalysts that accelerate chemical reactions, enabling relatively fast detection.

    • Analyte Role: In enzyme-based sensors, the analyte can be either:

      • (i) Enzyme substrate (S): The enzyme converts the substrate into a product (P).

      • (ii) Enzyme inhibitor (I): The enzyme's activity is reduced by the inhibitor.

    • Signal Generation: In both cases, the reaction product or the change in reaction rate is used to generate a signal, although the sensor's response to analyte concentration will differ.

Protein Structure: A Quick Reminder

  • Proteins as Copolymers: Linear co-polymers of just twenty amino acids, exhibiting amazing structural variety.

  • Amino Acid Diversity: Students should know the different categories of amino acids (small, aliphatic, alcohols, sulfur-containing, aromatic, acidic, basic, amides) and their general properties (hydrophobic/hydrophilic, charged at neutral pH).

  • Amino Acid Functionality: Each amino acid has common NH2NH_{2} (alpha-amino) and COOHCOOH (alpha-carboxyl) groups attached to a central alpha-carbon, but different side chains (R-groups).

    • The NH2NH_{2} and COOHCOOH groups are very reactive and can be used for biomolecule immobilization on surfaces.

    • Side chains also contain reactive functional groups crucial for immobilization.

  • Peptide Bonds & Polypeptides:

    • Dipeptides and polypeptides form through peptide bonds, where most alpha-amino and alpha-carboxyl groups are consumed.

    • The N-terminus (amino end) and C-terminus (carboxyl end) remain reactive at the ends of the polypeptide chain.

  • Levels of Protein Structure:

    • Primary Structure: The linear sequence of amino acids in a polypeptide chain. This is crucial because even proteins with low sequence homology (e.g., Chymotrypsin and Thrombin with 30%30\% homology) can have almost identical folds, highlighting the importance of sequence-to-structure relationships.

    • Secondary Structure: Defines the local folding/conformation of protein segments, primarily stabilized by patterns of hydrogen bonding between backbone atoms.

      • Alpha-helix: A common motif where the COCO group of residue 'n' forms a hydrogen bond with the NHNH group of residue 'n+4n+4'. Often depicted as ribbons or rods, with side chains pointing outwards. HH bonds are approximately 2.86 A˚2.86\ Å long.

      • Beta-strands & Beta-sheets: Beta-strands are polypeptide chains in beta-sheets where the backbone is almost fully extended (distance between adjacent AAs is 3.5 A˚3.5\ Å vs 1.5 A˚1.5\ Å in alpha-helix). Peptide carbonyls point in alternating directions. Depicted by broad arrows pointing towards the carboxyl-terminus.

        • Directionality: Beta-strands can be arranged in antiparallel (N-terminus of one strand adjacent to C-terminus of another) or parallel (directionally aligned) arrangements.

        • Hydrogen Bonding in Beta-sheets:

          • Antiparallel: NHNH- and COCO-groups of each amino acid are hydrogen bonded to the COCO- and NHNH-group respectively of a partner on the adjacent beta-strand.

          • Parallel: For each amino acid, the NHNH-group is HH-bonded to the COCO-group of one amino acid on the adjacent strand, while the COCO-group is HH-bonded to the NHNH-group on the amino acid two residues further along the chain.

        • Beta-sheets are critical structural elements, often comprising 44 to 10+10+ strands. Most proteins contain both alpha-helices and beta-sheets for stability.

    • Tertiary Structure: Describes the global three-dimensional folding of the polypeptide chain, assembling different elements of secondary structure into a particular arrangement. Amino acid residues in the active site are brought together. Many proteins have distinct structural domains (e.g., Pyruvate kinase is a 3-domain protein), which are fundamental units of tertiary structure and useful for protein engineering.

    • Quaternary Structure: Describes the assembly of multiple polypeptide chains (subunits) in proteins when more than one is present (e.g., Glucose isomerase, Phosphorylase).

      • Active sites are often formed by a pair of subunits.

      • Interwoven arrangements (like in Glucose Isomerase) can lead to high stability, resisting dissociation.

  • Maintaining Protein Structure and Activity:

    • Proteins are only active if their unique tertiary/quaternary structure is maintained.

    • Stabilized by a variety of covalent (e.g., disulfide bonds, SSS-S) and non-covalent interactions (e.g., hydrogen bonds, hydrophobic interactions).

    • In water-soluble proteins, hydrophilic amino acids are on the surface, while hydrophobic groups are shielded in the interior, with hydrophobic interactions being critical for fold integrity.

    • Importance of Protein Structure Knowledge:

      • Understanding stability (single vs. multi-subunit, overall fold).

      • Identifying amino acid residues at/near the binding/catalytic site for immobilization chemistry.

      • Determining availability/relative position of C- and N-terminus for immobilization methods.

      • Enabling optimization and performance improvements through protein engineering.

Why Enzymes are Useful in Biosensors

  • Key Advantages:

    • Sensitivity: Can detect very low concentrations of analytes.

    • Selectivity: Highly specific for their substrates, minimizing interference.

    • Stability/Reproducibility: Desirable for practical applications.

    • Ease of Integration: Can be readily integrated with various types of transducers.

    • Signal Amplification: Enzymes can catalyze multiple reactions, leading to amplified signals.

  • Historical and Commercial Success: Enzymes dominated the biosensors field in the 1990s, with enzyme-based glucose biosensors for diabetics remaining the biggest commercial success story.

Examples of Enzyme-based Biosensors

Luciferase Biosensors for ATP Detection

  • Principle: Luciferases are enzymes that convert energy into light (bioluminescence).

    • Bacterial luciferase reaction: FMNH<em>2+RCHO+O</em>2FMN+RCOOH+H2O+lightFMNH<em>{2} + RCHO + O</em>{2} \rightarrow FMN + RCOOH + H_{2}O + light (490nm490nm).

    • Firefly luciferase reaction: Luciferin+ATPLuciferyl adenylate+PPiLuciferin + ATP \rightarrow Luciferyl\ adenylate + PPi, followed by Luciferyl adenylate+O2Oxyluciferin+AMP+lightLuciferyl\ adenylate + O_{2} \rightarrow Oxyluciferin + AMP + light (560nm560nm).

  • ATP as an Analyte:

    • Early-stage cell breaking: Monitoring quality of erythrocytes in blood banks (though better assays are now available).

    • Hygiene Monitoring: Detecting bacteria on surfaces.

  • Hygiene Monitoring with Luciferase:

    • Traditional Method: Cotton swab followed by petri dish culture takes about a day for results.

    • Luciferase Assay: Takes minutes.

    • Commercial Products: e.g., Lumitester, using bacterial luciferase to measure bioluminescence from ATP decomposition.

    • AMP-ATP Circulation Technology (Patented): Allows measurement of both ATP and AMP as part of the ATP cycle, offering better sensitivity and more stable light signals.

      • In heat-treated foods, ATP breaks down to AMP, so detecting both provides a more reliable assessment of hygiene.

    • Measurement Procedure: Moistening a swab, wiping the surface, inserting it into a sensor, and obtaining results in 10\sim 10 seconds.

    • Performance: Comparative analysis in hospital kitchens (280 spots) showed discrepancies with traditional microbiology, with the biosensor being more sensitive.

    • Beyond Kitchens: Used for hygiene monitoring in various environments.

  • Airborne ATP Detection:

    • System Components:

      1. Condensation system to concentrate aerosols (suspension of particles/droplets in a gas).

      2. ATP extraction from captured bacteria (lysis of microorganisms).

      3. Bioluminescence detection of ATP.

    • Flow Rate: e.g., 2 L/min2\ L/min (older), 100 L/min100\ L/min (newer, battery-operated/hand-held devices).

    • Performance: Dynamic range from 1012 M10^{-12}\ M to 103 M10^{-3}\ M ATP. practically real-time detection (107 E.coli/mL10^{7}\ E.coli/mL produces detectable ATP).

    • Applications: Air monitoring for military, health, and general air quality control in public places (e.g., transportation systems).

    • Recent Relevance: Used for COVID and airborne allergens.

SARS-CoV-2 Detection: Advanced Biosensors

  • Electrode-based Virus Detection (Nature Com, 2023):

    • Virus captured by antibodies (ABs) immobilized on an electrode.

    • Detection based on oxidation of Tyrosine present on viral proteins.

    • Efficient, fast (5 mins detection), and portable aerosol sampler integrated with AB-based biosensor.

    • Critically, addresses the current lack of automated real-time airborne SARS-CoV-2 detection devices.

    • Offline air sampling (collection, then lab analysis) is commonly used, making real-time portable devices an advancement.

  • Antibody-based Detection (Nature Biomed Eng, 2021):

    • Utilizes a Luciferase design to detect serological antibodies, monitoring vaccination response.

    • Patient antibodies are incubated with SARS-CoV proteins (fused to LgBiT/SmBiTLgBiT/SmBiT split luciferase fragments).

    • Active luciferase is only reconstructed when antibody arms bind to both LgBiTLgBiT and SmBiTSmBiT sensors (i.e., 50%\sim 50\% of antibodies are detected).

    • Provides dose-dependent luminescence signal, allowing for quantitative measurement of antibody response, unlike many qualitative lateral flow tests.

Glucose Sensor: Glucose Oxidase (GOx)

  • Challenge: Chemically detecting glucose in a blood sample without separation is difficult due to other active compounds.

  • Solution: Enzyme electrodes modify the electrode tip to specifically measure enzymatic reactions.

  • Principle: Glucose Oxidase catalyzes the reaction: Glucose+O<em>2+H</em>2OGluconic acid+H<em>2O</em>2Glucose + O<em>{2} + H</em>{2}O \rightarrow Gluconic\ acid + H<em>{2}O</em>{2}

    • At neutral pH, gluconic acid (product) dissociates to give COOCOO^{-} and H+H^{+}.

    • The reaction can be followed by monitoring pH.

  • Fabrication (pH Electrode based):

    1. Start with a conventional pH electrode.

    2. Add a membrane that is permeable to SS (glucose) and PP (gluconic acid) but not to the enzyme (EE).

    3. Immobilize GOx (or other enzyme) between two membranes.

    4. This creates an enzyme electrode, functioning as a biosensor.

  • Clark-type Oxygen Electrode: Early biosensors like the Clark electrode measured oxygen consumption (rather than pH change) as glucose is oxidized, consuming O2O_{2}.

Polyphenol Oxidase (PPO) "Bananatrode"

  • Concept: A plant-based biosensor made from banana, which contains plenty of PPO.

  • Reaction: PPO catalyzes the oxidation of dopamine to dopamine quinone (consuming O2O_{2}).

  • Application: Dopamine detection.

Organophosphate Hydrolases (OPAA) for Neurotoxins

  • Analytes: Practically important neurotoxins like Sarin (chemical warfare agent), Dichlorvos (insecticide), Paraoxon (organophosphorus pesticide).

  • Enzyme: Organophosphate hydrolases (e.g., Aryldialkylphosphatase, EC 3.1.8.1) catalyze the hydrolysis of P-O bonds.

  • Mechanism: Hydrolysis products are strong acids.

  • Detection: Can be done with a pH-sensitive device due to the change in acidity.

  • Relevance: Many organophosphates are banned in various countries.

Acetylcholinesterase (AChE)-based Biosensors (Inhibitor Detection)

  • Commonality of Analytes: Sarin, paraoxon, dichlorvos, and many other warfare agents/pesticides are powerful inhibitors of Acetylcholinesterase (AChE).

  • AChE General Function: Hydrolyzes Acetylcholine into choline and acetic acid ($CH_3COOH$).

    • AChE is a serine esterase with a catalytic triad (Ser, His, Glu) and is a very fast enzyme.

    • Involved in neurotransmission (parasympathetic neuron).

  • Biosensor Principle: Detection is based on the inhibition of the enzyme's activity by the agent being detected.

    • Clinical Relevance: For clinical diagnostics, red blood cell cholinesterase (RBC) and plasma pseudocholinesterase levels are determined (different context).

  • Detection Schemes:

    • pH-based assay: Monitoring pH changes due to acetic acid production.

    • Amperometric/Optical Detection: Using acetylthiocholine as a substrate, which produces thiocholine. Thiocholine can be further modified or detected electrochemically.

    • Multi-enzyme System (Biosensors and Bioelectronics, 2020):

      1. AChE converts acetylthiocholine to thiocholine and CH3COOHCH_3COOH.

      2. Choline Oxidase (ChOx) converts thiocholine to H<em>2O</em>2H<em>2O</em>2.

      3. Horseradish Peroxidase (HRP) oxidizes H<em>2O</em>2H<em>2O</em>2 and luminol, causing luminol to emit light (chemiluminescence).

    • Application: Foldable paper-based biosensors for pesticide detection (e.g., chlorpyrifos, recently banned in EU).

    • Compatibility with Smartphones: Integrated light detectors (cameras) in smartphones provide sufficient sensitivity for colorimetric or chemiluminescence analysis (though sometimes less sensitive).

Neuraminidase for Influenza Detection

  • Analyte: Influenza virus (RNA viruses, A and B subtypes).

  • Enzyme: Viral neuraminidase.

  • Function: Neuraminidase cleaves sialic acids from cell surface glycoproteins of host cells, essential for virus replication (exiting the cell).

  • Biosensor Principle (e.g., Zstat-Flu):

    1. Swab taken from patient's throat, specimen extracted/diluted.

    2. Add a chromogenic or luminescence-based substrate.

    3. Incubate for 20\sim 20 minutes.

    4. Result: Blue color or light emission indicates infection.

  • Detection: Reliably detects both influenza A and B but cannot differentiate between clades/subtypes as all possess neuraminidase.

Enzyme Properties and Engineering

  • Desired Enzyme Properties for Biosensors: Sensitivity, selectivity, stability/reproducibility, ease of integration, signal amplification.

  • If Suitable Enzyme is Not Available: Properties can be engineered through:

    • Rational Protein Engineering: Knowledge-based structural alterations, such as amino acid substitutions or combining/moving protein domains. Requires high-resolution protein structure and detailed knowledge.

    • Directed Evolution: Introduction of a very large number of gene mutations followed by high-throughput screening (HTS) to select proteins with desired characteristics.

      • Challenge: Screening all combinations is impractical (e.g., 205020^{50} combinations for 50 positions is 1.23×10651.23 \times 10^{65}).

      • Solution: Construct libraries smartly to increase hit rate, have great HTS capabilities (10610^6 samples/day routine, 10810^8 doable), and good screening methods (looking only for desired traits).

      • Process (e.g., for thermostability):

        1. Generate a library of mutants (e.g., via error-prone PCR).

        2. Mutant enzymes expressed in a suitable host.

        3. Assay at a temperature above normal inactivation temperature (e.g., 40C40^{\circ}C).

        4. Most denature, but a few survive.

        5. Pick surviving colony, use as starting point for a new library for assay at an even higher temperature (e.g., 45C,50C,55C,60C45^{\circ}C, 50^{\circ}C, 55^{\circ}C, 60^{\circ}C).

        6. This iterative process mimics natural evolution ("adapt or die").

      • Example: Lactate Oxidase (LOX): Directed evolution increased LOX half-life at 70C70^{\circ}C by 36\sim 36 times, significantly prolonging LOX-based biosensor lifetime.

        • Application: Lactate levels in serum indicate oxygenation state of tissues (ischemic conditions). Used in life-threatening surgery, intensive therapy, and sports monitoring (lactate build-up).

        • Recent Implementation (Nano Letters, 2025): Real-time lactic acid monitoring in sweat using highly sensitive, selective, and reproducible LOX-based sensors with a wide detection range.

Advanced Biosensor Designs and Rational Protein Engineering

  • When Directed Evolution is Insufficient: Directed evolution is fast and less expensive if HTS is available but cannot be used for everything (e.g., re-designing luciferase's binding domain for every analyte).

  • Modular Luciferase-based Biosensor Platform (Nature, 2021):

    • Concept: Design luciferase with a closed (dark) state and open (luminescent) state, where analyte binding drives the switch from closed to open.

    • Goal: A modular platform easily repurposed for different targets, where conformational change is independent of analyte's molecular details.

    • Two Protein Components:

      1. "lucCage": Comprises a cage domain, a latch domain with a target-binding motif, and a split luciferase fragment ($SmBiT$).

      2. "lucKey": Contains a key peptide that binds to the open state of lucCage and another split luciferase fragment ($LgBiT$), complementary to $SmBiT$.

    • Mechanism:

      • Closed State: lucCage cannot bind lucKey, preventing SmBiT/LgBiT interaction (no luminescence).

      • Open State: Analyte binding to the target-binding motif causes a conformational change, allowing lucKey to bind to lucCage, bringing SmBiT and LgBiT together to form active luciferase (luminescence).

    • COVID Biosensor Application: Engineered "lucCageRBD" with a protein binder (pM affinity to SARS-CoV-2 spike protein RBD) detected monomeric RBD (15 pM LOD) and full trimeric spike protein (47 pM LOD) with light signal changes. Works in body fluids (e.g., 20%20\% diluted serum).

  • Split RNA Polymerase Cell-Free Biosensor (Sci Adv, 2025):

    • Concept: A cell-free biosensor based on a split T7 RNA polymerase fused to affinity domains (e.g., nanobodies, Nb) against a protein target/analyte.

    • Mechanism: Target analyte drives polymerase reassembly, inducing reporter expression (e.g., LacZ) that produces a colorimetric readout (e.g., yellow pigment CPRG to purple CPR).

    • Application: COVID detection, working in serum and saliva.

  • Enzyme-Switch "BLA-BLIP" Biosensor for Therapeutic Drug Monitoring (Biosensors & Bioelectronics, 2023):

    • Problem: Therapeutic monoclonal antibodies (TmAb) for cancer/autoimmune diseases have large interpatient variability in pharmacokinetics, requiring dosage optimization.

    • Sensor: In its closed state, \beta-lactamase (BLA) is inhibited by \beta-lactamase inhibitor protein (BLIP). The sensor also has two small binding proteins (Affimers) specific to variable regions of the target antibody.

    • Mechanism: Binding of the therapeutic mAb causes a conformational change, removing BLIP and activating BLA. BLA-catalyzed reaction generates a red product (colorimetric detection).

    • Performance: Detects sub-nM therapeutic antibodies (e.g., Humira) in serum.

  • Enzyme-amplified DNA Detection (Inhibitor-DNA-Enzyme, IDE, Complex):

    • Principle: Enzyme is conjugated with a single-stranded DNA (ssDNA) tagged with an enzyme inhibitor.

    • Initial State: Enzyme is inactive because the flexible ssDNA allows the inhibitor to get into the active site ("intramolecular" inhibition).

    • Detection: Binding of target DNA (complementary to ssDNA) leads to the formation of a rigid double-stranded DNA (dsDNA) duplex, pulling the inhibitor out of the active site.

    • Signal: The activated enzyme cleaves its substrate, generating an optical signal (light).

Enzyme Kinetics: Essential for Biosensor Operation

  • Importance: Understanding enzyme kinetics (the relationship between reaction rate and substrate concentration, and factors affecting it) is critical for achieving good performance.

  • Michaelis-Menten Equation: Provides the relationship between initial reaction rate (vv), maximum reaction rate (V<em>maxV<em>{max}), substrate concentration ([S][S]), and Michaelis constant (K</em>mK</em>m):

    • v=V<em>max[S]K</em>m+[S]v = \frac{V<em>{max}[S]}{K</em>m + [S]} This describes how the initial rate declines at low substrate concentrations, approaching a constant rate at high substrate concentrations.

  • Implications for Different Substrate Concentrations:

    • If [S] >> Km: The equation simplifies to vV</em>maxv \approx V</em>{max}.

      • This effectively represents a zero-order reaction, where the rate is largely independent of substrate concentration.

    • If [S] << Km: The equation simplifies to vV</em>max[S]K<em>m=K</em>app[S]v \approx \frac{V</em>{max}[S]}{K<em>m} = K</em>{app}[S] (where KappK_{app} is a constant).

      • This effectively represents a first-order reaction, where the rate is proportional to the reactant's concentration.

  • Operational Considerations for Substrate-based Biosensors:

    • Biosensor 1 (measuring reaction rate): If the biosensor measures analyte concentration via the reaction rate (signal proportional to rate), it must operate where the rate increases approximately linearly with analyte concentration. Therefore, the enzyme needs a K<em>mK<em>m above the detection range ([S] << Km operation) to ensure sensitivity to changes in analyte concentration. If operating near V<em>maxV<em>{max} (point 1 on MM plot), the rate is insensitive to [S][S]. For a linear response, operate below K</em>mK</em>m (e.g., points 3 or 4).

    • Biosensor 2 (measuring total product): If the biosensor determines total analyte concentration by converting all analyte-substrate into product, it needs the enzyme to work fast.

      • Therefore, it should operate above K<em>mK<em>m (i.e., using an enzyme with low K</em>mK</em>m and high VmaxV_{max}) to ensure rapid conversion, unlike Biosensor 1. The total product will be proportional to the initial analyte concentration.

  • Operational Considerations for Inhibitor-based Biosensors:

    • Analyte as Inhibitor (Example: Biosensor 3 (Substrate) vs. Biosensor 4 (Inhibitor)):

      • "On" sensor (Analyte = Substrate): Signal goes up with increasing analyte concentration.

      • "Off" sensor (Analyte = Inhibitor): Signal goes down with increasing analyte concentration (the more 'A' is present, the slower the enzyme works, less product accumulated).

    • Types of Inhibition:

      • Competitive Inhibition: Inhibitor binds to the active site, competing with the substrate. Can be outcompeted by high substrate concentration.

        • Effect: Apparent K<em>mK<em>m increases, but V</em>maxV</em>{max} is unaffected.

        • Optimal [S][S] for competitive inhibitor detection: Low [S][S] (but not too low) is generally better. At very high [S][S], the inhibitor is outcompeted, leading to very low sensitivity (small signal change). Optimal sensitivity is often achieved in the middle range.

      • Non-competitive Inhibition: Inhibitor binds to a site distinct from the active site, affecting the enzyme's catalytic efficiency without affecting substrate binding. Cannot be outcompeted by high substrate concentration.

        • Possible Mechanism: Remote inhibitor binding affects catalytic group positioning.

        • Effect: V<em>maxV<em>{max} decreases, but K</em>mK</em>m is unchanged.

        • Optimal [S][S] for non-competitive inhibitor detection: Higher [S][S] is generally better to maximize signal change difference between inhibited and uninhibited states.

Summary of Enzyme Biosensors

  • Enzymes are widely used as sensing biomolecules in biosensors.

  • If a suitable enzyme is available, it is often the bioreceptor of choice, especially when extremely high sensitivity is not required.

  • Desired properties (selectivity, sensitivity, stability) can be significantly improved through protein engineering or directed evolution.

  • In enzyme sensors, the analyte can act as either a substrate or an inhibitor of the enzyme.

  • A thorough understanding of protein structures and enzyme kinetics is essential for selecting (or engineering/evolving) the appropriate enzyme and determining optimal operating conditions.

  • Enzymes are also routinely employed for signal amplification. This will be discussed further in the next lecture.